China chip stocks rally on self-reliance bets, Nvidia scrutiny
Investing.com -- Johnson & Johnson announced Thursday a $2 billion commitment to expand its manufacturing presence in North Carolina with a new 160,000+ square foot facility at FUJIFILM’s biopharmaceutical site in Holly Springs.
The 10-year investment will create approximately 120 new jobs and is part of J&J’s strategy to manufacture the majority of its advanced medicines in the United States for U.S. patients.
"Johnson & Johnson has more manufacturing facilities in the U.S. than in any other country, and we continue to strengthen our presence here," said Joaquin Duato, Chairman and Chief Executive Officer of Johnson & Johnson (NYSE:JNJ).
"With the recent signing of the One Big Beautiful Bill Act, we continue to expand our investment in the U.S. to lead the next era of healthcare innovation."
The company plans to announce additional U.S. manufacturing facilities and expansions of current sites in the coming months.
In March, J&J committed to investing $55 billion over the next four years to support U.S. manufacturing, research and development, and technology investments.
Construction is also progressing on J&J’s Wilson, North Carolina facility, which will employ more than 500 people when fully operational and create approximately 5,000 construction jobs during development.
The company’s U.S. investments include extensive R&D infrastructure for developing treatments in oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.